Cleveland Clinic releases testosterone replacement therapy study

The clinical trial found such therapy does not lead to an increase major adverse cardiac events for men with low testosterone.

Related Keywords

United States ,Steven Nissen ,Endocrine Society ,Clinical Research ,Drug Administration ,Labcorp Drug Development ,Cleveland Clinic Coordinating Center ,Vascular Thoracic Institute At Cleveland Clinic ,Cleveland Clinic Led ,New England Journal ,Replacement Therapy ,Long Term Vascular Events ,Efficacy Response ,Thoracic Institute ,Cleveland Clinic ,